Therapeutic effects of metoprolol, a beta-blocker, on lowering of blood pressure in hypertensive patients with obstructive sleep apnea (OSA) is similar to that of amlodipine, according to a new study published in the journal Sleep and Breathing. The findings further demonstrate that metoprolol could not decrease heart rate (HR) during the nighttime in such patients.
Metoprolol (marketed under the trade name Lopressor) belong to the class of medications called selective β₁ receptor blocker. It works by slowing heart rate and relaxing blood vessels to decrease blood pressure and improve blood flow. However, its use for the management of hypertensive patients with OSA has been controversial for a long time.
For the study, the researchers assigned the hypertensive subjects with OSA to metoprolol and amlodipine groups. The two groups received 12 weeks of oral either metoprolol (47.5 mg once daily) or amlodipine (5 mg once daily) treatment. At baseline and after the 12-week treatment period, 24-h ambulatory blood pressure monitoring was performed in both groups.
- Both of metoprolol and amlodipine treatments significantly lowered 24-h blood pressure (BP) (from 143/88 to 132.3/81.6 mmHg; from 141.3/84.5 to 133.7/80.8 mmHg), daytime BP (from 146/90.2 to 136.4/84.6 mmHg; from 145.1/87.6 to 138.2/84.1 mmHg), and nighttime BP (from 139.1/83.9 to 125.7/76.2 mmHg; from 134.5/78.5 to 125.8/74.1 mmHg).
- There were no significant differences between the groups in BP variability.
- metoprolol significantly reduced daytime heart rate, while 24-h and nighttime HR values had no remarkable changes compared with baseline.
“Metoprolol had similar therapeutic effects on BP lowering as amlodipine and could not decrease HR during the nighttime in hypertensive patients with OSA,” concluded the authors.
For further reference log on to https://doi.org/10.1007/s11325-018-1688-5